Study Design of an Expanded Access Protocol of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Patients 60-75 Years of Age with Secondary Acute Myeloid Leukemia
Larson, Melissa L, Rubenstein, S. Eric, Schiller, Gary J, Solomon, Scott R, Louie, Arthur C, Paulsen, Kim H, Lin, Tara L
Published in Biology of blood and marrow transplantation (01.03.2017)
Published in Biology of blood and marrow transplantation (01.03.2017)
Get full text
Journal Article
CPX-351: A Randomized Phase 2b Study of CPX-351 v. Intensive Salvage Therapy in '65 Yo First Relapse AML Patients: Initial Efficacy and Safety Report
Cortes, Jorge E., Feldman, Eric J, Goldberg, Stuart L., Rizzieri, David A., Paulsen, Kim H., Louie, Arthur C., Kolitz, Jonathan E.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
271 - Study Design of an Expanded Access Protocol of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Patients 60-75 Years of Age with Secondary Acute Myeloid Leukemia
Larson, Melissa L., Rubenstein, S. Eric, Schiller, Gary J., Solomon, Scott R., Louie, Arthur C., Paulsen, Kim H., Lin, Tara L.
Published in Biology of blood and marrow transplantation (01.03.2017)
Published in Biology of blood and marrow transplantation (01.03.2017)
Get full text
Journal Article